| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $15.2M | -52.6% |
| Cost of Revenue | $5.7M | -46.6% |
| Gross Profit | $9.6M | -55.5% |
| R&D Expense | $7.6M | -56.4% |
| SG&A Expense | $21.4M | -24.8% |
| Operating Income | -$30.2M | +39.9% |
| Pre-tax Income | -$28.7M | -12.8% |
| Income Tax | $74K | -89.7% |
| Net Income | -$28.8M | -10.0% |
| EPS (Basic) | -$3.81 | +67.3% |
| EPS (Diluted) | -$3.81 | +67.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.4M | -64.8% |
| Accounts Receivable | $4.0M | -44.6% |
| Inventory | $2.7M | -21.5% |
| Current Assets | $12.8M | -52.9% |
| Total Assets | $15.8M | -51.9% |
| Current Liabilities | $38.4M | +103.8% |
| Total Liabilities | $93.0M | -16.1% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.9M | +31.6% |
| Capital Expenditures | $611K | +0.0% |
| Investing Cash Flow | -$611K | +0.0% |
| Financing Cash Flow | $19.0M | -6.1% |
| Free Cash Flow | -$29.6M | +31.1% |
| -$77.2M |
| +1.0% |